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Background: Gut microﬂora play a crucial role in the biotransformation of ginsenosides to compound K
(CK), which may affect the pharmacological effects of ginseng. Prebiotics, such as NUTRIOSE, could
enhance the formation and consequent absorption of CK through the modulation of gut microbial
metabolic activities. In this study, the effect of a prebiotic ﬁber (NUTRIOSE) on the pharmacokinetics of
ginsenoside CK, a bioactive metabolite of ginsenosides, and its mechanism of action were investigated.
Methods: Male SpragueeDawley rats were given control or NUTRIOSE-containing diets (control
diet þ NUTRIOSE) for 2 wk, and ginseng extract or vehicle was then orally administered. Blood samples
were collected to investigate the pharmacokinetics of CK using liquid chromatographyetandem mass
spectrometry. Fecal activities that metabolize ginsenoside Rb1 to CK were assayed with fecal specimens
or bacteria cultures.
Results: When ginseng extract was orally administered to rats fed with 2.5%, 5%, or 10% NUTRIOSE
containing diets, the maximum plasma concentration (Cmax) and area under the plasma concentration
etime curve values of CK signiﬁcantly increased in a NUTRIOSE content-dependent manner. NUTRIOSE
intake increased glycosidase activity and CK formation in rat intestinal contents. The CK-forming ac-
tivities of intestinal microbiota cultured in vitro were signiﬁcantly induced by NUTRIOSE.
Conclusion: These results show that prebiotic diets, such as NUTRIOSE, may promote the metabolic
conversion of ginsenosides to CK and the subsequent absorption of CK in the gastrointestinal tract and
may potentiate the pharmacological effects of ginseng.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Ginseng (the root of Panax ginseng Meyer, Araliaceae), which
contains ginsenosides as major bioactive ingredients, is popularly
used as functional food or dietary supplement in Asian countries
[1]. Ginsenosides exhibit different biological activities, such as anti-
inﬂammatory and antitumor activities [2,3]. To exert these phar-
macological actions, ginsenosides are metabolized by human in-
testinal microbes after oral administration [4,5]. The major
ginsenosides contained in ginseng (ginsenosides Rb1, Rb2, and Rc)College of Pharmacy, Kyung Hee U
erms of the Creative Commons At
ribution, and reproduction in any
rk.
e Korean Society of Ginseng, Publare metabolized to 20-O-b-D-glucopyranosyl-20(S)-proto-
panaxadiol [compound K (CK); Fig. 1], a deglycosylated metabolite
of ginsenosides, by human intestinal microbiota prior to being
absorbed into the blood [6e10]. CK exhibits antitumor, anti-in-
ﬂammatory, and antiallergic activities more potently than the
parental ginsenoside Rb1 and is considered a major bioactive
metabolite responsible for the pharmacological actions of orally
administered ginseng [3,4,11]. Therefore, intestinal microbes
involved in CK formation play an important role in exerting the
pharmacological effects of ginseng.niversity, 1, Hoegi, Dongdaemun-gu, Seoul 130-701, Korea.
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Fig. 1. Chemical structures of ginsenoside Rb1 and compound K.
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stimulate the growth and/or activity of the gastrointestinal
microﬂora and promote host well-being and health [12]. Dietary
sources such as acacia gums, beans, inulin sources, raw oats, un-
reﬁned wheat, unreﬁned barley, and yacon contain prebiotics.
NUTRIOSE, a nonviscous, soluble ﬁber derived from wheat and
corn, is produced through a digestion-like process and thermal
treatment and is considered a prebiotic. This prebiotic ﬁber is
resistant to hydrolysis in the small intestine owing to a structure of
linear and branched glucosidic linkages so that it may be available
for bacterial fermentation in the gut [13]. According to previous
reports, NUTRIOSE increased the number of intestinal Lactobacillus
spp. and Bacteroides [14e16]. Short- and long-term NUTRIOSE
supplementation in human volunteers signiﬁcantly increased fecal
a/b-glucosidase activities and improved intestinal bowel disease
through a protective immune effect [14]. NUTRIOSE has beneﬁcial
effects on colonic ecology, which may lead to improvements in
insulin resistance, energy intake, and body composition [17].
In this study, the pharmacokinetics of CK following oral
administration of ginseng extract was investigated in rats treated
with NUTRIOSE as prebiotics. In addition, the effects of NUTRIOSE
on intestinal bacterial metabolic activities, in particular CK-forming
activities, were investigated to characterize its mechanism of action
on ginseng pharmacokinetics and pharmacodynamics.
2. Materials and methods
2.1. Materials
Ginseng extract was prepared, and ginsenoside Rb1 (purity
>92%) was isolated according to themethod that we had previously
reported [8]. The extracted powder contained 8.9% ginsenoside
Rb1, 8.5% ginsenoside Rg1, and 1.4% ginsenoside Rd, but CK was not
detected. NUTRIOSE was kindly donated by Roquette (Lestrem,
France). CK was purchased from Fleton Natural Products Co., Ltd.
(Chengdu, China).
2.2. Human participants
The participants consisted of three healthy Koreanmen (average
age, 73  2 years). Exclusion criteria included smoking and current
medication, especially regular or current use of antibiotics. The
recruitment of participants and the consent procedure as well as
the collection of their stools were approved by the Ethics Com-
mittee for the Care and Use of Clinical Study in the Medical School,
Kyung Hee University, Seoul, Korea (KHS-IRB-12-011-1). The par-
ticipants provided their written informed consent to participate in
the study.
2.3. Animals
Male SpragueeDawley rats (210e240 g) were supplied by the
Orient Experimental Animal Breeding Center (Gyunggi-do, Korea).All animals were housed in wire cages (2 rats per cage) maintained
at a temperature range of 20e22C and 50  10% humidity, fed
standard laboratory chow (Samyang Co., Seoul, Korea), and allowed
water ad libitum. All experiments were performed in accordance
with the National Institutes of Health and Kyung Hee University
Guides for Laboratory Animals Care and Use and approved by the
Committee for the Care and Use of Laboratory Animals in the Col-
lege of Pharmacy, Kyung Hee University (KHP-2012-04-06-R1).
2.4. Pharmacokinetic study
Male SpragueeDawley rats were orally administered ginseng
extract or vehicle after receiving control or NUTRIOSE-containing
diets (control diet þ NUTRIOSE) for 2 wk. Blood samples (200 mL)
were collected from the tail vein at 0 h, 1 h, 2 h, 4 h, 8 h, 12 h, 16 h,
20 h, and 24 h after administration of ginseng extract and centri-
fuged for 10 min at 4,000  g to prepare the plasma samples. The
samples were analyzed using liquid chromatographyetandem
mass spectrometry analyses according to a previously reported
method [18]. Plasma concentration data for individual rats were
analyzed with a noncompartmental method by using WinNonlin
Professional 3.1 software (Scientiﬁc Consulting, Inc., Lexington, KY,
USA). The area under the plasma concentrationetime curve (AUC)
was calculated by using the trapezoidal rule. The maximum plasma
concentration (Cmax) and the time to reach Cmax (Tmax) were esti-
mated directly from the plasma concentrationetime proﬁles.
2.5. Metabolic activity measurement
Fecal a-D-glucosidase, b-D-glucosidase, b-D-xylosidase, and a-L-
rhamnosidase activities were tested with rat gastrointestinal con-
tents [19]. Fecal activities that metabolize ginsenoside Rb1 to CK
were assayed with fecal specimens or bacteria cultures [20]. For
fecal bacteria culture, rat or human fecal specimens (approximately
1 g) were collected in plastic cups and then carefully mixed with a
spatula and suspended in 9 mL cold saline. Fecal bacterial sus-
pension was centrifuged at 500  g for 5 min. The resulting su-
pernatant is inoculated in control or 1% NUTRIOSE-containing Gifu
anaerobic medium (GAM; glucose-free broth) and cultured for 24 h.
The culture media were collected by centrifugation at 10,000  g
for 20min. The precipitate was used as a crude enzyme preparation
to assay the ginsenoside Rb1 to CK metabolizing activity [20].
3. Results
3.1. Formation of CK from ginsenoside Rb1 or ginseng extracts in rat
and human fecal suspension
Prior to investigation of prebiotic effects on CK formation
mediated by gut microbacterial enzymes, the metabolic activity for
CK formation from ginsenoside Rb1 or ginseng extracts were
measured in rat and human fecal suspensions (Fig. 2). The incu-
bation of ginsenoside Rb1 or ginseng extracts in fecal suspension
Fig. 2. Compound K-forming activities from ginsenoside Rb1 or ginseng extract in rat
and human feces.
Fig. 3. Plasma concentrations of compound K after oral administration of ginseng
extract (2,000 mg/kg) in rats fed with or without NUTRIOSE. Rats were orally
administered ginseng extracts at a dose of 2,000 mg/kg after being fed control or
NUTRIOSE-containing diet for 2 wk. Group fed 10% NUTRIOSE-containing diet (N10);
group administered ginseng extract after being fed control diet (N0-G) and 2.5% (N2.5-
G), 5% (N5-G), or 10% (N10-G) NUTRIOSE-containing diet. All values are indicated as the
mean  standard deviation (n ¼ 5). *p < 0.05 compared with N0-G.
Table 1
Pharmacokinetic parameters of compound K after oral administration of ginseng
extract in rats treated with NUTRIOSE
Group Tmax (h) Cmax (ng/mL) AUC (ng h/mL)
N0-G 15.2  1.8 24.1  5.5 153.1  30.6
N2.5-G 12.8  3.3 24.0  9.3 187.2  24.0
N5-G 12.0  0.0* 38.8  21.8 218.5  60.7
N10-G 12.0  0.0* 54.4  26.2* 429.9  160.8*
Tmax, maximum drug concentration time; Cmax, maximum plasma concentration;
AUC, area under the blood concentration curve. Group administered ginseng extract
after being fed control diet (N0-G) and 2.5% (N2.5-G), 5% (N5-G), or 10% (N10-G)
NUTRIOSE-containing diet. All values are indicated as the mean  SD (n ¼ 5).
*p < 0.05 compared with N0-G.
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were 28.0  2.9 nmol/h/g and 34.1 18.9 nmol/h/g, respectively, in
rat and human feces. In ginseng extract samples, the metabolic
rates of rat and human feces were 38.4  16.9 nmol/h/g and
96.3 80.7 nmol/h/g, respectively. As for ginsenoside Rb1 samples,
CK formation rates in human and rat fecal suspensions were
comparable, and the variation between individuals was relatively
low. However, in ginseng extract samples, a higher variation was
observed, particularly in human samples and the difference be-
tween humans and rats was greater. Ginseng extract contains
various protopanaxadiol ginsenosides that can be transformed to
CK, and thus individual differences may be greater. Accordingly, the
subsequent experiments in rats were carried out with ginsenoside
Rb1 as a substrate to minimize the variations between individuals
and species.
3.2. Effect of NUTRIOSE on plasma pharmacokinetics of CK
To understand the effect of NUTRIOSE on CK pharmacokinetics,
plasma concentrations of CK after oral administration of ginseng
extract (2,000 mg/kg) were determined in rats fed a control or
NUTRIOSE-containing diet for 2 wk. The mean plasma concentra-
tionetime proﬁles of CK are shown in Fig. 3. The pharmacokinetic
parameters are provided in Table 1. As shown in Table 1, CK Cmax
values increased with increasing NUTRIOSE content; the Cmax value
of CK in the 10% NUTRIOSE-treated group (N10-G; 54.4  26.2 ng/
mL) was >2 times higher than that of the control group (G;
24.1  5.5 ng/mL), and the difference was statistically signiﬁcant
(p ¼ 0.04). The AUC values also increased in a NUTRIOSE content-
dependent manner. The AUC of the N10-G group was 2.8 times
greater than that of the control group (153.1  30.6 ng h/mL vs.
429.9  160.6 ng h/mL, p ¼ 0.006). Thus, CK systemic exposure was
signiﬁcantly increased in NUTRIOSE-fed rats. In addition, CK Tmax
was reached earlier in NUTRIOSE-fed rats as compared to controls
(12.0  0.0 h vs. 15.2  1.8 h, p ¼ 0.004).
3.3. Effect of NUTRIOSE on glycosidase activities of intestinal
microbiota
Ginsenosides have different sugar moieties such as glucose,
rhamnose, and xylose. Thus, biotransformation of ginsenosides to
CK involves glycosidic bond cleavage by gut microbial hydrolysis. To
investigate the effects of NUTRIOSE on ginsenoside-metabolizingenzyme activities of intestinal microbiota, the glucosidase activities
of intestinal contents weremeasured in rats treatedwith NUTRIOSE
for 2 wk (the intestinal contents were collected from the rats used
for the pharmacokinetic study described above). As shown in Fig. 4,
a/b-D-glucosidase activities were increased by NUTRIOSE treat-
ment. This result is accordance with previously reported data [14].
a-L-Rhamnosidase activity was also increased by treatment with
NUTRIOSE. The mean b-xylosidase activity increased as well,
although this result was not statistically signiﬁcant. The effect of
NUTRIOSE appeared to be content-dependent based on the data
obtained for the ginseng dosed groups (N0-G, N2.5-G, N5-G, and
N10-G).
3.4. Effect of NUTRIOSE on CK formation by intestinal microbiota
To investigate the effects of NUTRIOSE on CK formation by gut
bacterial metabolism, CK-forming enzyme activities of rat intestinal
contents were measured following NUTRIOSE treatment. Ginse-
noside Rb1 was used as a substrate to determine CK-forming
enzyme activities. Ginsenoside Rb1 is a representative proto-
panaxadiol ginsenoside and the most abundant ingredient of
ginseng extract, which is extensively metabolized by gut microﬂora
to yield CK. The resulting data showed biotransformation of gin-
senoside Rb1 to CK by fecal bacteria increased with increasing
NUTRIOSE content (Fig. 5A). The metabolic rates in the 5% and 10%
Fig. 4. Effects of NUTRIOSE on glycosidase activities of rat intestinal contents. (A) a-D-Glucosidase activity; (B) b-D-glucosidase activity; (C) b-D-xylosidase activity; and (D) a-L-
rhamnosidase activity. N0, control. Other sample codes are as indicated in Fig. 3. All values are presented mean  standard deviation (n ¼ 4). #p < 0.05 compared with N0. *p < 0.05
compared with N0-G.
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h/g, respectively) were >10 times higher than that in the control
group (26  14 nmol/h/g).
3.5. Effect of NUTRIOSE on CK-forming activities of rat and human
fecal microﬂora cultured in GAM
To conﬁrm whether NUTRIOSE could induce the CK-forming
activity of intestinalmicrobiota, fecalmicrobiota of rats and humans
were cultured in vitro in GAM broth with or without NUTRIOSE for
24 h, and formation rates of CK from ginsenoside Rb1 wereFig. 5. Effect of NUTRIOSE on the biotransformation of Rb1 to compound K (A) in rat intest
with NUTRIOSE-containing diets for 2 wk and the metabolic activity of the intestinal con
(control) or 1% NUTRIOSE-containing GAM broth for 24 h and the metabolic activity was me
compared with dextrose. **p < 0.01 compared with control diet group (n ¼ 4).measured (Fig. 5B). The addition of NUTRIOSE signiﬁcantly induced
the metabolic activity of cultured fecal microbiota in both rats and
humans. The CK-forming activities of NUTRIOSE-supplemented
fecal microbiota cultures were 4.5-fold (4.5  2.0, p ¼ 0.01) and
5.5-fold (5.5 2.3, p¼ 0.03) higher in rats and humans, respectively,
compared with those in dextrose-supplemented cultures.
4. Discussion
Dietary food or herbal supplements or medicines are orally
ingested and their ingredients inevitably come in contact with theinal contents and (B) in rat and human fecal microbiota cultures. (A) Rats were treated
tents was measured. (B) Rat and human fecal bacteria were cultured in 1% dextrose
asured. Ginsenoside Rb1 was used as a substrate at a concentration of 0.1mM. *p < 0.05
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harbors > 1,000 microbial species, which is about 10 times the
number of body cells [1,21]. The intestinal microbiota metabolizes
exogenous xenobiotics, including dietary compounds and phyto-
chemicals, as well as endogenous compounds secreted into the
gastrointestinal tract [22e25]. Thus, intestinal microbiota may
transform a considerable proportion of orally administered herbal
supplement ingredients to their corresponding metabolites, and in
numerous cases to bioactive metabolites, before the ingredients are
absorbed from the gastrointestinal tract [1,6,7]. Therefore, intesti-
nal microbiota is considered to play an important role in regulating
the biological activities of functional foods or herbal supplements
such as ginseng.
This study demonstrated that the intake of NUTRIOSE elevated
the plasma concentration level of CK after the oral administration
of ginseng. This is thought to result from the increase in the for-
mation and consequent absorption of CK in the gastrointestinal
tract by NUTRIOSE. Prebiotics are known tomodulate and generally
enhance the metabolic activities of gut microﬂora [26]. This is
consistent with the result of this study; NUTRIOSE treatment
increased the glycosidase activities of intestinal or fecal microbiota
and promoted the biotransformation of ginsenoside Rb1 to CK.
Thus, NUTRIOSE intake enhanced the uptake of CK by increasing its
formation through induction of ginsenoside-metabolizing enzyme
activity of gastrointestinal microbiota.
CK is a ginsenosidewith potent chemoprevention and anticancer
activities. The CK content of raw ginseng extract is minimal or
negligible; however, CK is a major metabolite after the oral admin-
istration of protopanaxadiol ginsenosides and could be a major
bioactive metabolite responsible for the pharmacological effects of
ginseng [23,27]. As ginsenosides are converted to CK mainly by gut
microﬂora, themetabolic activity of the intestinal microbiotawould
be closely related to the pharmacological activity of ginseng.
However, the intestinal CK forming activities seem to be
signiﬁcantly different among individuals. According to the report
by Lee et al [10], in the CK formation assay with the fecal suspen-
sion collected from 32 human participants, the highest metabolic
activity was found to be >20 times of the lowest metabolic activity.
This result is in accordance with our data (Fig. 2). In addition, such
an individual variation was reﬂected to the plasma concentration
proﬁles; the area under the concentration curve (AUC) values
calculated after the oral administration of ginseng extract powder
also showed a large variation (221.98  221.42 ng h/mL). Even CK
was not detected in the plasma samples of some participants. Thus,
the effects of ginseng intake might not be minimal to those in-
dividuals. In these cases, it would be helpful to activate the meta-
bolic activities of gut microbiota to enhance the biotransformation
of ginsenosides to active metabolites such as CK. Based on our re-
sults, prebiotics may be useful to maximize the pharmacological
effects of ginseng.
Many papers have reported the involvement of the gut micro-
ﬂora in the biotransformation of ginsenosides [7,27]. However, to
our knowledge, there has been no study showing that the phar-
macokinetics of ginsenosides is affected by alterations in gut
microﬂora metabolic activities. The present study experimentally
demonstrated this by using a prebiotic-treated rat model. Further-
more, the results suggested that the intake of prebiotics may
enhance the pharmacological effects of functional foods or herbal
supplements that are likely to be metabolized by gut microﬂora.Conﬂicts of interest
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